64388 A randomized study to evaluate the efficacy and adverse effects of oral Tofacitinib, oral Methotrexate and Intramuscular Methotrexate in moderate to severe Palmoplantar Psoriasis - 01/09/25

Doi : 10.1016/j.jaad.2025.05.433

ananditha kopparthy
resident in the department of DVL, Maharajah's institute of medical sciences
Gopal KVT Professor and Head of the department, department of DVL, Maharajah's institute of medical sciences

Pallavi Sai Adapa
resident in the department of DVL, Maharajah's institute of medical sciences

Sravanthi A
assistant professor, department of DVL, Maharajah's institute of medical sciences

Il testo completo di questo articolo è disponibile in PDF.

Commercial Disclosure: NA.

Esportazione

Vol 93 - N° 3S

P. AB108 - settembre 2025 Ritorno al numero

Articolo precedente

63400 A randomized phase 2 proof-of-concept study to evaluate the efficacy and safety of topical bimiralisib application in patients suffering from actinic keratosis on the face and/or scalp and/or back of hands over a 2 and 4-week treatment period
Tatjana Steybe, Hanna Lindemann, Bruno Osterwalder, David Allman, Natasa Cmiljanovic, Maria Cristina Russo, Emilie Burgener, Zhouxing Su, Olivier Gaide, Alexander Andreas Navarini

| Articolo seguente

63531 A Rare Case of Discoid Lupus Erythematosus and Consecutive Linear Morphea
Michelle Swedek, Amylee Sam, Ashley Elsensohn, Linda Golkar

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

64388 A randomized study to evaluate the efficacy and adverse effects of oral Tofacitinib, oral Methotrexate and Intramuscular Methotrexate in moderate to severe Palmoplantar Psoriasis - 01/09/25

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL